We are live on
!
Find out more
Lexicon Pharmaceuticals
LXRX
LXRX
107 hedge funds and large institutions have $540M invested in Lexicon Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 41 increasing their positions, 26 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
109% more call options, than puts
Call options by funds: $2.83M | Put options by funds: $1.36M
58% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 26
5% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 22
0% more funds holding
Funds holding: 107 → 107 (0)
2.47% less ownership
Funds ownership: 83.99% → 81.52% (-2.5%)
24% less capital invested
Capital invested by funds: $710M → $540M (-$170M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
107
Holders Change
–
Holders Change %
0%
% of All Funds
1.86%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
23
Increased
41
Reduced
26
Closed
22
Calls
$2.83M
Puts
$1.36M
Net Calls
+$1.48M
Net Calls Change
+$255K
Top Buyers
| 1 |
JP Morgan Chase
New York
|
+$4.43M |
| 2 |
BlackRock
New York
|
+$3.58M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.61M |
| 4 |
D.E. Shaw & Co
New York
|
+$1.91M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$1.66M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.03M |
| 2 |
Morgan Stanley
New York
|
-$2.75M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.71M |
| 4 |
Renaissance Technologies
New York
|
-$1.22M |
| 5 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
-$1.05M |
